Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without these mutations, according to…
PPP2R1A mutations linked to improved survival in ovarian clear cell carcinoma
